Skip to main content
. 2020 Jan 8;21(1):45–57. doi: 10.1080/15532739.2019.1692750

Table 4.

Use of fertility preservation services in our study population, subdivided by groups based upon receiving information about fertility preservation, groups who underwent psychological evaluation, who initiated gender affirming hormones and groups based upon geographical region. Missing data were not included in this analysis (TW: %, GNB: 5, 8.9%). Differences between groups were calculated by Fisher’s exact t test. Other factors that did not significantly affect the use of fertility preservation services among the study population (gender identity groups: P = 0.362, sexual attration (P-values range 0.121–1.000), parental desire: P = 0.325, having accessed health care: P = 0.181, underwent breast augmentation: P = 0.116, orchiectomy: P = 0.084 or vaginoplasty: P = 0.097, economic status: P = 0.245, educational level: P = 0.239, mother tongue: P = 0.063) were not included.

Use of fertility preservation services Gametes frozen Considering freezing in the future No gametes frozen Not applicable Differences between groups
Total 15 (8.7%) 16 (9.3%) 115 (66.9%) 26 (15.1%)  
Received information on fertility Yes 14 (14.9%) 7 (7.4%) 61 (64.9%) 12 (12.8%) P = 0.017
No 1 (1.4%) 9 (12.3%) 50 (68.5%) 13 (17.8%)
Psychological evaluation Yes 15 (12.2%) 10 (8.1%) 84 (68.3%) 14 (11.4%) P = 0.035
No 0 (0%) 6 (22.2%) 16 (59.3%) 5 (18.5%)
Gender affirming hormones Yes 15 (15.6%) 3 (3.1%) 67 (69.8%) 3 (3.1%) P < 0.001
No 0 (0%) 13 (26.0%) 30 (60.0%) 7 (14.0%)
Region Flanders 12 (9.8%) 9 (7.4%) 78 (63.9%) 23 (18.9%) P = 0.021
Wallonia 1 (3.4%) 2 (6.9%) 24 (82.8%) 2 (6.9%)
Brussels Capital Region 2 (11.1%) 5 (27.8%) 11 (61.1%) 0 (0%)